We are analyzing https://link.springer.com/article/10.1007/s10555-006-7894-9.

Title:
Recent advances in MMP inhibitor design | Cancer and Metastasis Reviews
Description:
The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor. This inhibitor is yet to be found. The reasons for this failure include shortcomings in the chemistry of these compounds (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biology. Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is critical, yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degradation) regulated. This review summarizes the progression of chemical structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 8,280,528 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

google, scholar, pubmed, cas, matrix, cancer, metalloproteinase, chem, inhibitors, inhibitor, mmp, med, res, metalloproteinases, clin, tumor, inhibition, phase, selective, bioorg, cell, biol, lett, potent, study, curr, cells, rev, activity, metastasis, drug, breast, lung, article, mobashery, patients, drugs, synthesis, design, anticancer, development, metalloprotease, human, opin, oncol, liu, trial, int, structural, pharmacol,

Topics {✒️}

n-i-propoxy-n-biphenylsulfonylaminobutylhydroxamic acids n-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids tnf-alpha converting enzyme cancer cell-adipocyte interaction/crosstalk phenoxyphenyl sulfone n-formylhydroxylamines substituted gamma-keto carboxylate structure-based drug discovery intra-arterial infusion drug month download article/chapter hydroxamate-based peptide inhibitors urokinase-type plasminogen activator phenyl]sulfonyl]-n-hydroxy-2 mechanism-based gelatinase inhibitor extracellular matrix-derived peptides t-cell lymphoma model selective pyrone-based inhibitors tissue remodelling-related diseases transition-state-analogue inhibitors mmp-expressing tumor cells potent pyrimidinetrione-based inhibitors metalloprotease-dependent process regulated cancer-induced bone disease chelating zinc-binding groups small-cell lung cancer silico fragment-based approach potent mechanism-based inhibitors matrix metalloprotease-9-deficient mice mouse tumor model o'brien pm cell-mediated substrate cleavage sulfonamide hydroxamic acids compound screening mechanism alpha-sulfonylhydroxamic acids reduces tumor growth including broad mmp mechanism-based inhibitor oncologic drug development human meprin alpha matrix metalloproteinase inhibitor matrix metalloprotease inhibitor phenyl]sulfonyl]amino highly specific inhibitor endothelial cell lines privacy choices/manage cookies collagen-induced arthritis structure-based design matrix metalloproteinase inhibitors matrix metalloproteinase-1 inhibitors phosphinic peptide inhibitor tumor cell invasion

Questions {❓}

Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA: Osteoarthritis—an untreatable disease?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Recent advances in MMP inhibitor design
         description:The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor. This inhibitor is yet to be found. The reasons for this failure include shortcomings in the chemistry of these compounds (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biology. Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is critical, yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degradation) regulated. This review summarizes the progression of chemical structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.
         datePublished:
         dateModified:
         pageStart:115
         pageEnd:136
         sameAs:https://doi.org/10.1007/s10555-006-7894-9
         keywords:
            Matrix metalloprotease
            Metalloproteinase gelatinase
            Collagenase
            Cancer Research
            Oncology
            Biomedicine
            general
         image:
         isPartOf:
            name:Cancer and Metastasis Reviews
            issn:
               1573-7233
               0167-7659
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jed F. Fisher
               affiliation:
                     name:University of Notre Dame
                     address:
                        name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shahriar Mobashery
               affiliation:
                     name:University of Notre Dame
                     address:
                        name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Recent advances in MMP inhibitor design
      description:The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor. This inhibitor is yet to be found. The reasons for this failure include shortcomings in the chemistry of these compounds (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biology. Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is critical, yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degradation) regulated. This review summarizes the progression of chemical structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.
      datePublished:
      dateModified:
      pageStart:115
      pageEnd:136
      sameAs:https://doi.org/10.1007/s10555-006-7894-9
      keywords:
         Matrix metalloprotease
         Metalloproteinase gelatinase
         Collagenase
         Cancer Research
         Oncology
         Biomedicine
         general
      image:
      isPartOf:
         name:Cancer and Metastasis Reviews
         issn:
            1573-7233
            0167-7659
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jed F. Fisher
            affiliation:
                  name:University of Notre Dame
                  address:
                     name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shahriar Mobashery
            affiliation:
                  name:University of Notre Dame
                  address:
                     name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer and Metastasis Reviews
      issn:
         1573-7233
         0167-7659
      volumeNumber:25
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Notre Dame
      address:
         name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
         type:PostalAddress
      name:University of Notre Dame
      address:
         name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jed F. Fisher
      affiliation:
            name:University of Notre Dame
            address:
               name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
               type:PostalAddress
            type:Organization
      name:Shahriar Mobashery
      affiliation:
            name:University of Notre Dame
            address:
               name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
      name:Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(472)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.67s.

LINK . SPRINGER . COM {}